Until now, global medical imaging has been run as a reactive, high-barrier infrastructure model similar to the old system. At present, diagnostic imaging has...
Genentech, a member of the Roche Group , announced positive results from the Phase II FENopta study evaluating investigational oral fenebrutinib in adults with...
